Goldman PE arm buys MyEyeDr in $2.7B deal, producing 3.5x return for Altas Partners

optometry, ophthalmology, medical, private equity, vision care, M&A, healthcare, merger, Goldman Sachs, MyEyeDr, retail
Eva-Katalin/E+/Getty Images
Altas Partners is poised to generate an about 3.5x return on MyEyeDr through a sale of the optometry giant valued at $2.7 billion, according to a source familiar with the matter. Goldman Sachs through West Street Capital Partners VII, a fund ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.